HEALWELL Delivers 316% Revenue Growth and Increasing Customer Traction in Q1-2026
HEALWELL’s revenue explodes 316% and cash piles up, but a skeptical market keeps the stock pinned near its lows—doubting the AI narrative without a path to true net profit.
HEALWELL AI reported Q1-2026 financial results for the period ended March 31, 2026. Revenue was $33.2 million, up 316% from $8.0 million in Q1-2025. Gross profit rose 340% to $19.5 million, with gross margin improving to 59% from 56%. Adjusted EBITDA swung to positive $0.7 million against a loss of $2.3 million a year earlier, while IFRS net loss narrowed to $6.8 million from $14.1 million. Cash increased to $21.9 million from $18.6 million at year‑end 2025. The release highlights a first AI contract with a major Middle Eastern governmental health system, a multi‑million‑dollar U.S. Health Information Exchange software deal, the launch of the WELLTRUST patient‑identification platform, and the continued integration of DARWEN™ AI capabilities. Segment revenue shows Healthcare Software at $30.6 million (+439% YoY) and AI & Data Sciences at $2.6 million (+13% YoY). Board changes were noted with the appointment of Orion Health CEO Brad Porter and the departure of Ian McCrae.
The Q1-2026 numbers are strong in absolute terms, but they are squarely in line with the trajectory established by earlier releases: - FY2025 results (Mar. 19, 2026) already showed record revenue of $103.8 M, positive full‑year Adjusted EBITDA, and guided to ~10% Adjusted EBITDA margin in 2026. - The U.S. HIE contract and Middle East AI contract were pre‑announced in February–March 2026. - Revenue, margin, and EBITDA figures are all consistent with a company scaling its Orion Health acquisition and beginning to harvest integration synergies.
Because the market was already aware of these positive trends, the release adds little genuinely new, unexpected, or market‑moving information. The stock closed at $0.95 on May 7, 2026—down from $0.97 the prior day and unchanged from the levels seen in late April—indicating no surprise uplift. The news is therefore routine‑positive, reflecting expected execution rather than a game‑changing event.
HEALWELL AI Inc. (TSX: AIDX, OTCQX: HWAIF) is a pure‑play healthcare AI and SaaS company following a series of divestitures in late 2025 that shed its clinic operations. Its flagship platform, DARWEN™, is a clinically validated AI engine for real‑world evidence generation, early disease detection, and clinical decision support. Through the acquisition of Orion Health (effective Apr 1, 2025), the company also offers interoperability, health information exchange (HIE), and population health software. The integrated Amadeus AI platform embeds DARWEN™ capabilities into Orion’s global client base, serving governmental health systems, hospitals, and life‑sciences partners in North America, the Middle East, Europe, and Asia‑Pacific.